Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approvalByBruce GilPublishedMarch 28, 2025
Elon Musk and his team just defended DOGE's 'revolution.' Here are some takeawaysByWilliam GavinPublishedMarch 28, 2025
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundupByBruce GilPublishedMarch 28, 2025
Delaware's 'Billionaire's Bill'; RFK Jr.'s FDA cuts; and Trump's auto tariffs: Politics RoundupByWilliam GavinPublishedMarch 28, 2025
Walmart's eggless Easter, Old Navy's AI bet, and Target cuts bonuses: Retail news roundupByFrancisco VelasquezPublishedMarch 28, 2025
9 grocery store staples that could take a big hit if Republicans cut SNAP fundingByFrancisco VelasquezPublishedMarch 28, 2025
Wegovy sales took a hit this year. Novo's CEO blames off-brand competitionByBruce GilPublishedMarch 27, 2025
The Democratic FTC commissioners Trump fired are now suing the FTCByWilliam GavinPublishedMarch 27, 2025
RFK Jr. plans to cut 3,500 jobs at the FDA, as staff is reportedly already struggling with workloadByBruce GilPublishedMarch 27, 2025
Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’sByBruce GilPublishedMarch 27, 2025
Ferrari's luxury cars are about to get more expensive, thanks to Trump's tariffsByWilliam GavinPublishedMarch 27, 2025
Trump's auto tariffs will have a 'significant' impact on Tesla, Elon Musk saysByWilliam GavinPublishedMarch 27, 2025
JPMorgan drops its price targets for Ford, GM, and Ferrari as Trump's 'draconian' tariffs loomByWilliam GavinUpdatedMarch 27, 2025
Now playing Gap is betting Old Navy and AI will help solidify its position in retailPublishedMarch 26, 2025
Tracking Trump's trade war: Where tariffs are in effect — and what's coming nextByWilliam GavinUpdatedMarch 27, 2025
The ad biz is bracing for slower growth this year — and the economy's to blameByBruce GilPublishedMarch 26, 2025
